Humana reaffirms FY26 adjusted EPS guidance of at least $9

Humana reaffirmed its FY26 adjusted EPS guidance of at least $9, saying it is exceeding its goal of top-quartile results in 2027 Medicare Advantage star ratings and expects a 2028 benefit from one-time investments and return to shareholders.

Detected & updated continuously · Source: Nebula